Trials / Completed
CompletedNCT04226092
Pre-SunBeam TEWL AUC
Pre-SunBeam Pilot Study: Comparative Assessment of TEWL Measurements From AquaFlux vs. Handheld GPSkin Pro in Young Children With and Without AD
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 33 (actual)
- Sponsor
- Northwestern University · Academic / Other
- Sex
- All
- Age
- 0 Years – 3 Years
- Healthy volunteers
- Accepted
Summary
Transepidermal Water Loss (TEWL) measurements are a valuable tool to determine the integrity of a person's skin barrier. In patients with skin conditions, like atopic dermatitis, skin barrier can be disrupted or weakened, leading to a more severe phenotype and disease characteristics. There are several commercially available TEWL measuring devices, including the Aquaflux AF200 and the GPSkin Barrier Pro. This study is a pilot study to determine if these two devices produce similar readings for TEWL/skin barrier on patients with and without atopic dematitis (AD). The research team would like to investigate whether these devices are comparable for initial TEWL readings as well as after several rounds of tape strips have been collected from the skin. Tape strips are small circular adhesives, much like tape, that remove the very outermost layers of skin cells. It will be important to know if both of these devices provide correlative values for TEWL once the outermost layers of the skin have been removed by tape stripping.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | GPSkin Barrier Pro | This study is a pilot study to determine if this device produces similar readings than Aquaflux AF200 for TEWL/skin barrier on patients with and without atopic dematitis (AD). |
| DEVICE | Aquaflux AF200 | This study is a pilot study to determine if this device produces similar readings than GPSkin Barrier Pro for TEWL/skin barrier on patients with and without atopic dematitis (AD). |
Timeline
- Start date
- 2019-11-07
- Primary completion
- 2020-07-31
- Completion
- 2020-07-31
- First posted
- 2020-01-13
- Last updated
- 2020-09-07
Locations
2 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT04226092. Inclusion in this directory is not an endorsement.